Stay informed about the latest updates and insights from the Conscio Group, the group of companies dedicated to improving health worldwide through quality science.

  • 6 June 2023

    Ekolab and Conscio Group join forces

    Ekolab joins the Conscio Group, enhancing our analytical capabilities and solidifying our position in pharmaceutical, nutrition, and technology solutions.

  • 31 May 2023

    Clinical Tips – Drug Interactions In Advanced Clinical Trial Design

    Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.

  • 29 March 2023

    Transdermal Patches, Films and Topicals – Putting the Skin in the Game

    Today we talk about novel drug delivery systems and in vitro testing techniques. Learn about our work with transdermal patches, orally dissolving films, topical products and Franz cell testing.

  • 14 March 2023

    Clinical Tips – Benefits of Sequential Designs in Bioequivalence Studies

    Discover the power of sequential designs for bioequivalence studies, a crucial step in generics development: Their practical implementation, statistical analysis, and the well-being of the volunteers.

  • 16 February 2023

    A Prescription Against EU Medicine Shortages – Outsourcing Stabilities

    We highlight the reasons behind current EU drug shortages and the key role CROs and outsourced stability testing play in diversifying drug production.

  • 25 January 2023

    Pharmaceutical Offshore Outsourcing in the USA: Opportunities & Misconceptions

    Dr. Jeffrey Kiel, founder and CEO of Kiel Laboratories, talks about offshore outsourcing in the USA and working with Quinta-Analytica

  • 21 December 2022

    From Houston to Munich – Innovation & Compounding

    Interested in the latest trends in pharmacy compounding, pharma innovation and first-hand know-how from a senior member of USP’s Compounding Expert Committee? Dr. Gus Bassani of PCCA, a leading compounding pharmacy supplier from Houston, USA, and Dr. Markus Dachtler of Gen-Plus, a pharma R&D and manufacturing firm from Munich, Germany, share lessons from their successful collaboration.

  • 30 October 2022

    CPHI Frankfurt 2022: See you there!

    Conscio is attending CPHI 2022 in Frankfurt

  • 11 August 2022

    Gen-Plus + Conscio Partnership

    Today we proudly announce that Gen-Plus GmbH & Co. KG, a Munich-based pharma R&D and manufacturing expert, has become a new member of the Conscio Group.